These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 8825871

  • 1. "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype.
    Mastrangeli A, Harvey BG, Yao J, Wolff G, Kovesdi I, Crystal RG, Falck-Pedersen E.
    Hum Gene Ther; 1996 Jan; 7(1):79-87. PubMed ID: 8825871
    [Abstract] [Full Text] [Related]

  • 2. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype.
    Mack CA, Song WR, Carpenter H, Wickham TJ, Kovesdi I, Harvey BG, Magovern CJ, Isom OW, Rosengart T, Falck-Pedersen E, Hackett NR, Crystal RG, Mastrangeli A.
    Hum Gene Ther; 1997 Jan 01; 8(1):99-109. PubMed ID: 8989999
    [Abstract] [Full Text] [Related]

  • 3. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG, Hackett NR, El-Sawy T, Rosengart TK, Hirschowitz EA, Lieberman MD, Lesser ML, Crystal RG.
    J Virol; 1999 Aug 01; 73(8):6729-42. PubMed ID: 10400771
    [Abstract] [Full Text] [Related]

  • 4. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA.
    Brody SL, Metzger M, Danel C, Rosenfeld MA, Crystal RG.
    Hum Gene Ther; 1994 Jul 01; 5(7):821-36. PubMed ID: 7526901
    [Abstract] [Full Text] [Related]

  • 5. Circumventing the immune response to adenovirus-mediated gene therapy.
    Kass-Eisler A, Leinwand L, Gall J, Bloom B, Falck-Pedersen E.
    Gene Ther; 1996 Feb 01; 3(2):154-62. PubMed ID: 8867863
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.
    Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC.
    Gene Ther; 1994 May 01; 1(3):192-200. PubMed ID: 7584081
    [Abstract] [Full Text] [Related]

  • 7. [Aerosol administration of a replication defective recombinant adenovirus expressing normal human cDNA-CFTR in the respiratory tractus in patients with cystic fibrosis].
    Bellon G, Calmard L, Thouvenot D, Levrey H, Jagneaux V, Poitevin F, Malcus C, Accart N, Séné C, Layani MP, Aymard M, Bienvenu J, Courtney M, Döring G, Gilly B, Gilly R, Lamy D, Morel Y, Paulin C, Perraud F, Rodillon L, So S, Touraine F, Schatz C, Pavirani A.
    C R Seances Soc Biol Fil; 1996 May 01; 190(1):109-42. PubMed ID: 8881273
    [Abstract] [Full Text] [Related]

  • 8. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG, Hackett NR, Ely S, Crystal RG.
    Mol Ther; 2001 Feb 01; 3(2):206-15. PubMed ID: 11237677
    [Abstract] [Full Text] [Related]

  • 9. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ, McElvaney NG, Chu CS, Rosenfeld MA, Mastrangeli A, Hay J, Brody SL, Eissa NT, Danel C, Jaffe HA.
    Am J Respir Crit Care Med; 1995 Mar 01; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [Abstract] [Full Text] [Related]

  • 10. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.
    Yei S, Mittereder N, Wert S, Whitsett JA, Wilmott RW, Trapnell BC.
    Hum Gene Ther; 1994 Jun 01; 5(6):731-44. PubMed ID: 7948135
    [Abstract] [Full Text] [Related]

  • 11. In vitro assessment of variables affecting the efficiency and efficacy of adenovirus-mediated gene transfer to cystic fibrosis airway epithelia.
    Johnson LG, Pickles RJ, Boyles SE, Morris JC, Ye H, Zhou Z, Olsen JC, Boucher RC.
    Hum Gene Ther; 1996 Jan 01; 7(1):51-9. PubMed ID: 8825868
    [Abstract] [Full Text] [Related]

  • 12. Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation.
    Setoguchi Y, Jaffe HA, Chu CS, Crystal RG.
    Am J Respir Cell Mol Biol; 1994 Apr 01; 10(4):369-77. PubMed ID: 8136153
    [Abstract] [Full Text] [Related]

  • 13. Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
    Kaplan JM, St George JA, Pennington SE, Keyes LD, Johnson RP, Wadsworth SC, Smith AE.
    Gene Ther; 1996 Feb 01; 3(2):117-27. PubMed ID: 8867859
    [Abstract] [Full Text] [Related]

  • 14. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium.
    Scaria A, St George JA, Jiang C, Kaplan JM, Wadsworth SC, Gregory RJ.
    J Virol; 1998 Sep 01; 72(9):7302-9. PubMed ID: 9696826
    [Abstract] [Full Text] [Related]

  • 15. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.
    Lee ER, Marshall J, Siegel CS, Jiang C, Yew NS, Nichols MR, Nietupski JB, Ziegler RJ, Lane MB, Wang KX, Wan NC, Scheule RK, Harris DJ, Smith AE, Cheng SH.
    Hum Gene Ther; 1996 Sep 10; 7(14):1701-17. PubMed ID: 8886841
    [Abstract] [Full Text] [Related]

  • 16. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis.
    Zabner J, Ramsey BW, Meeker DP, Aitken ML, Balfour RP, Gibson RL, Launspach J, Moscicki RA, Richards SM, Standaert TA.
    J Clin Invest; 1996 Mar 15; 97(6):1504-11. PubMed ID: 8617884
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O, Ashbourne Excoffon KJ, Henning P, Melin P, Norez C, Gonzalez G, Karp PH, Magnusson MK, Habib N, Lindholm L, Becq F, Boulanger P, Zabner J, Hong SS.
    Hum Gene Ther; 2010 Mar 15; 21(3):251-69. PubMed ID: 19788389
    [Abstract] [Full Text] [Related]

  • 18. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
    Joseph PM, O'Sullivan BP, Lapey A, Dorkin H, Oren J, Balfour R, Perricone MA, Rosenberg M, Wadsworth SC, Smith AE, St George JA, Meeker DP.
    Hum Gene Ther; 2001 Jul 20; 12(11):1369-82. PubMed ID: 11485629
    [Abstract] [Full Text] [Related]

  • 19. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
    Rosenfeld MA, Yoshimura K, Trapnell BC, Yoneyama K, Rosenthal ER, Dalemans W, Fukayama M, Bargon J, Stier LE, Stratford-Perricaudet L.
    Cell; 1992 Jan 10; 68(1):143-55. PubMed ID: 1370653
    [Abstract] [Full Text] [Related]

  • 20. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus.
    Harvey BG, Leopold PL, Hackett NR, Grasso TM, Williams PM, Tucker AL, Kaner RJ, Ferris B, Gonda I, Sweeney TD, Ramalingam R, Kovesdi I, Shak S, Crystal RG.
    J Clin Invest; 1999 Nov 10; 104(9):1245-55. PubMed ID: 10545523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.